GlassScriptPhysician profile
Himanshu Shah
NPI 1629005210
$34,513.70
in general payments reported to CMS, 2019-2025
15 companies · $367 in 2025
The $367 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16K · 2020: $4,767 · 2023: $957 · 2024: $13K · 2025: $367.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $12K · Food and Beverage: $1,831 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $83.96.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $12,059.03 |
| Food and Beverage | $1,831.37 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $83.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Siemens Medical Solutions USA, INC. | $19,289.54 | 2019-2024 | Naeotom Alpha, Artis Icono Floor, Magnetom Sempra |
| Cook Research Incorporated | $12,925.90 | 2019-2020 | |
| Inari Medical, INC. | $1,799.19 | 2023-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Angiodynamics, INC. | $94.16 | 2024-2025 | Alphavac |
| Imperative Care, INC | $69.15 | 2025 | Symphony Catheter |
| Stryker Corporation | $63.03 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Penumbra, INC. | $58.25 | 2025 | Ruby Coil |
| Bayer Healthcare Pharmaceuticals INC. | $52.71 | 2023 | |
| Medtronic, INC. | $39.14 | 2024 | Abre |
| Amgen INC. | $35.96 | 2025 | Evenity |
| Argon Medical Devices, INC. | $31.59 | 2025 | Clot Management |
| Boston Scientific Corporation | $19.71 | 2025 | Embold Fibered |
| Cardiva Medical, INC. | $17.79 | 2024 | Cardiva Vascade 6/7f Vcs |
| E.R. Squibb & Sons, L.L.C. | $17.58 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Himanshu Shah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.